B. E. Blass et al. / Tetrahedron Letters 44 (2003) 2153–2155
2155
Scheme 3.
accomplished with either Amberlite azide ion exchange
resin5 or the more conventional Merrifield resin sup-
ported tetra-alkyl ammonium azide (prepared from the
commercially available polymer supported bromide)6 in
DMA over 72 hours. Removal of the resin by filtration
and then heating the reaction to 80°C in the presence of
1.0 equiv. of methyl propiolate provided the desired
1,2,3-triazole (8) via a 2+3 cycloaddition reaction
(Scheme 3). The products could then be isolated by
simple evaporation of the solvents.7 It is interesting to
note that the while benzyl chloride provide the desired
product in both reasonable yield and purity, the less
reactive b-chlorophenetole did not provide detectable
levels of the desired product. This is in direct contrast
to b-bromophenetole, suggesting that alkyl chlorides
that do not contain an additional activating feature are
not reactive enough under the conditions examined. An
examination of alternative solvents, such as EtOAc,
THF, DMF and 1,4-dioxane, demonstrated that the
reaction did occur, but the best results were obtained
with DMA. Both of the azide resins provided the
desired 1,2,3-traizoles in reasonable yields and purity,
but the Merrifield resin bound azide showed superior
swelling properties which may make it useful for addi-
tional chemistry that is not compatible with the Amber-
lite resin.
Riviere, M. E.; Karolchyk, M. A. Epilepsy Res. 2001, 43,
115–124.
3. Dorwald, F. Z., WO 9740025.
4. Blass, B. E.; Coburn, K. R.; Faulkner, A. L.; Hunn, C. L.;
Natchus, M. G.; Parker, M. S.; Portlock, D. E.; Tullis, J.
S.; Wood, R. Tetrahedron Lett. 2002, 43, 4059–4061.
5. Hassner, A.; Stern, M. Angew. Chem., Int. Ed. Engl. 1986,
25, 478.
6. Merrifield resin supported ammonium azide is prepared
from the commercially available polymer supported bro-
mide (3.5 mmol Br/g) as follows: 5.0 g of polymer sup-
ported bromide is suspended in 30 ml of DMA and 5.7 g
of NaN3 (5 equiv.) is added. After 48 h, the reaction is
filtered, washed with methanol, and dried to a solid with
IR showing a significant signal for azide at 2002 cm−1
.
7. Typical experimental procedure: To a suspension of azide
bound resin (250 mg) in DMA (6 ml) is added a halide (50
mg). The mixture is then agitated for 72 h at room
temperature. After the completion of the reaction (TLC),
the resin is filtered off. To the solution is then added
methyl propiolate (1 equiv.) and the reaction is stirred
overnight at 80°C. The solvent is then evaporated and the
desired product is isolated by reverse phase HPLC on a
C18 symmetry column (20×100 mm; 5 mm) using a linear
gradient from 100% water to 100% acetonitrile (0.02%
TFA in both solvents) over 15 min (20 ml/min flow rate).
Spectral data for Table 1: Entry 1 (1H NMR, 300 MHz,
CD3OD): l 3.30 (m, 2H), 3.75 (s, 3H), 4.50 (t, J=6.50 Hz,
2H), 7.09–7.20 (m, 5H), 8.33 (s, 1H). (M+H) 264. Entry 2
(1H NMR, 300 MHz, CD3OD): l 1.01 (d, J=4.0 Hz, 6H),
1.87 (q, J=7.0 Hz, 2H), 2.10 (m, 1H), 3.72 (m, 2H), 3.94
(s, 3H), 8.59 (s, 1H). (M+H) 198. Entry 3 and 4 (1H NMR,
300 MHz, CD3OD): l 3.90 (s, 3H), 5.66 (s, 2H), 7.31 (brs,
5H), 8.54 (s, 1H). (M+H) 218. Entry 5 (1H NMR, 300
MHz, CD3OD): l 1.69 (m, 2H), 2.02 (m, 2H), 2.49 (t,
J=7.30 Hz, 2H), 3.73 (s, 3H), 3.82 (s, 3H), 4.39 (t, J=7.00
Hz, 2H), 8.46 (s, 1H). (M+H) 242. Entry 6 (1H NMR, 300
MHz, CD3OD): l 1.77 (d, J=7.18 Hz, 3H), 3.77 (s, 3H),
5.46 (m, 1H), 6.98 (t, J=3.20 Hz, 1H), 7.34 (t, J=7.50 Hz,
2H), 7.66 (d, J=8.50 Hz, 2H), 8.77 (s, 1H). (M+H) 275.
Entry 7 (1H NMR, 300 MHz, CD3OD): l 3.84 (s, 3H),
3.70 (m, 2H), 4.40 (t, J=5.0 Hz, 2H), 6.82–6.89 (m, 3H),
7.17 (t, J=5.30 Hz, 2H), 8.55 (s, 1H). (M+H) 247. Entry 9
(1H NMR, 300 MHz, CD3OD): l 2.20 (m, 2H), 3.72 (t,
J=7.50 Hz, 2H), 3.93 (s, 3H), 7.06 (m, 1H), 7.40 (d,
J=8.0 Hz, 2H), 7.58 (m, 2H), 8.25 (s, 1H). (M+H) 271.
Entry 10 (1H NMR, 300 MHz, CD3OD): l 1.97 (s, 6H),
3.79 (s, 3H), 4.30 (m, 2H), 5.36 (m, 1H), 8.33 (s, 1H).
(M+H) 196. Entry 11 (1H NMR, 300 MHz, CD3OD): l
1.15 (m, 6H), 3.61 (m, 4H), 3.80 (s, 3H), 3.94 (m, 2H), 4.58
(m, 2H), 8.50 (s, 1H). (M+H) 292. Entry 12 (1H NMR, 300
MHz, CD3OD): l 1.30–1.46 (m, 11H), 1.88 (m, 2H), 3.83
(s, 3H), 4.38 (t, J=7.50 Hz, 2H), 8.38 (s, 1H). (M+H) 238.
In summary, we have developed a simple, two step
method for the preparation of libraries of functional-
ized 1,2,3-triazoles using a solid phase reagent. The
products are obtained in reasonable yields and purity.
References
1. (a) Gordon, E. W.; Gallop, M. A.; Barret, R. W.; Dower,
W. J.; Fodor, S. P. A. J. Med. Chem. 1994, 37, 1233–1252
1386-01; (b) Terret, N. K.; Gardner, M.; Gordon, D. W.;
Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135–
8173; (c) Bunin, B. A. The Combinatorial Index; Academic
Press, 1998; (d) Czarnik, A. W.; DeWitt, S. H. A Practical
Guide to Combinatorial Chemistry; American Chemical
Society, 1997.
2. (a) Cappellacci, L.; Franchetti, P.; Grifantini, M.; Messini,
L.; Lucacchini, A.; Martini, C. XIIIth Int. Symp. Med.
Chem. 1994, P13; (b) Sankyo, K. K. JP07017861-A; (c)
Kohn, E.; Liotta, L. A. WO9507695-A1; (d) Adams, A.
D.; Heck, J. V. US5350746-A; (e) Im, C.; Maiti, S. N.;
Micetich, R. G.; Daneshtalab, M.; Atchison, K.; Phillips,
O. A. J. Antibiot. 1994, 47, 1030–1040; (f) Alvarez, R.;
Velazquez, S.; San Felix, A.; Aquaro, S.; Clercq, E.; de
Perno, C. F. J. Med. Chem. 1994, 37, 4185–4194; (g)
Palhagen, S.; Canger, R.; Henriksen, O.; van Parys, J. A.;